Abstract

There is a growing interest in the role of timing of daily behaviors in improving health. However, little is known about the optimal timing of physical activity to maximize health benefits. We perform a cohort study of 92,139 UK Biobank participants with valid accelerometer data and all-cause and cause-specific mortality outcomes, comprising over 7 years of median follow-up (638,825 person-years). Moderate-to-vigorous intensity physical activity (MVPA) at any time of day is associated with lower risks for all-cause, cardiovascular disease, and cancer mortality. In addition, compared with morning group (>50% of daily MVPA during 05:00-11:00), midday-afternoon (11:00-17:00) and mixed MVPA timing groups, but not evening group (17:00-24:00), have lower risks of all-cause and cardiovascular disease mortality. These protective associations are more pronounced among the elderly, males, less physically active participants, or those with preexisting cardiovascular diseases. Here, we show that MVPA timing may have the potential to improve public health.

There is a growing interest in the role of timing of physical activity (PA) in improving health. Here, using a large-scale cohort study, the authors show that moderate-to-vigorous PA at the optimal time of day robustly predicts lower mortality risk and may maximize the beneficial effect of PA.

Details

Title
Associations of timing of physical activity with all-cause and cause-specific mortality in a prospective cohort study
Author
Feng, Hongliang 1   VIAFID ORCID Logo  ; Yang, Lulu 2   VIAFID ORCID Logo  ; Liang, Yannis Yan 2   VIAFID ORCID Logo  ; Ai, Sizhi 3 ; Liu, Yaping 4 ; Liu, Yue 2 ; Jin, Xinyi 2 ; Lei, Binbin 2 ; Wang, Jing 5   VIAFID ORCID Logo  ; Zheng, Nana 6 ; Chen, Xinru 7 ; Chan, Joey W. Y. 4   VIAFID ORCID Logo  ; Sum, Raymond Kim Wai 8 ; Chan, Ngan Yin 4 ; Tan, Xiao 9 ; Benedict, Christian 10   VIAFID ORCID Logo  ; Wing, Yun Kwok 4   VIAFID ORCID Logo  ; Zhang, Jihui 11   VIAFID ORCID Logo 

 Guangdong Academy of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangzhou, China (GRID:grid.410643.4); The Chinese University of Hong Kong, Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, Hong Kong SAR, China (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482) 
 Guangdong Academy of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangzhou, China (GRID:grid.410643.4) 
 The Affiliated Brain Hospital of Guangzhou Medical University, Center for Sleep and Circadian Medicine, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072); Heart Center, The First Affiliated Hospital of Xinxiang Medical University, Department of Cardiology, Weihui, China (GRID:grid.493088.e) (ISNI:0000 0004 1757 7279); The Chinese University of Hong Kong, Department of Psychiatry, Faculty of Medicine, Hong Kong SAR, China (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482) 
 The Chinese University of Hong Kong, Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, Hong Kong SAR, China (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482); The Chinese University of Hong Kong, Department of Psychiatry, Faculty of Medicine, Hong Kong SAR, China (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482) 
 The Affiliated Brain Hospital of Guangzhou Medical University, Center for Sleep and Circadian Medicine, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072); The Chinese University of Hong Kong, Department of Psychiatry, Faculty of Medicine, Hong Kong SAR, China (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482) 
 The Affiliated Brain Hospital of Guangzhou Medical University, Center for Sleep and Circadian Medicine, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072) 
 Guangdong Academy of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangzhou, China (GRID:grid.410643.4); The Affiliated Brain Hospital of Guangzhou Medical University, Center for Sleep and Circadian Medicine, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072) 
 The Chinese University of Hong Kong, Department of Sports Science and Physical Education, Faculty of Education, Hong Kong SAR, China (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482) 
 Zhejiang University School of Public Health and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Department of Big Data in Health Science, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X); Uppsala University, Department of Medical Sciences, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457) 
10  Uppsala University, Molecular Neuropharmacology, Department of Pharmaceutical Biosciences, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457) 
11  The Affiliated Brain Hospital of Guangzhou Medical University, Center for Sleep and Circadian Medicine, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072); The Chinese University of Hong Kong, Department of Psychiatry, Faculty of Medicine, Hong Kong SAR, China (GRID:grid.10784.3a) (ISNI:0000 0004 1937 0482); Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangdong Mental Health Center, Guangzhou, China (GRID:grid.10784.3a); Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072) 
Pages
930
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2777792096
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.